Golden Throat Holdings Reports Robust Financial Growth in 2024

Golden Throat Holdings Group Co Ltd ( (HK:6896) ) has shared an update.

Golden Throat Holdings Group Co Ltd announced its annual results for the year ended 31 December 2024, reporting a significant increase in financial performance. The company’s revenue rose by 23.3% to RMB1,185.0 million, and gross profit increased by 28.2% to RMB894.2 million compared to the previous year. The profit attributable to equity holders grew by 27.3% to RMB318.6 million. The Board has recommended a final dividend of HK$0.5 per share, subject to shareholder approval. This financial growth highlights the company’s strong market positioning and potential positive implications for stakeholders.

More about Golden Throat Holdings Group Co Ltd

Golden Throat Holdings Group Co Ltd is a company incorporated under the laws of the Cayman Islands, primarily engaged in the production and sale of healthcare products. The company is listed on the Hong Kong Stock Exchange and focuses on providing high-quality products to its customers.

YTD Price Performance: 22.53%

Average Trading Volume: 191,433

Technical Sentiment Signal: Sell

Current Market Cap: HK$2.94B

See more data about 6896 stock on TipRanks’ Stock Analysis page.